These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
580 related articles for article (PubMed ID: 19504616)
1. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes. Roselli M; Finamore A; Nuccitelli S; Carnevali P; Brigidi P; Vitali B; Nobili F; Rami R; Garaguso I; Mengheri E Inflamm Bowel Dis; 2009 Oct; 15(10):1526-36. PubMed ID: 19504616 [TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics. Mariman R; Kremer B; van Erk M; Lagerweij T; Koning F; Nagelkerken L Inflamm Bowel Dis; 2012 Aug; 18(8):1424-33. PubMed ID: 22162025 [TBL] [Abstract][Full Text] [Related]
3. Bifidobacterium infantis attenuates colitis by regulating T cell subset responses. Zuo L; Yuan KT; Yu L; Meng QH; Chung PC; Yang DH World J Gastroenterol; 2014 Dec; 20(48):18316-29. PubMed ID: 25561798 [TBL] [Abstract][Full Text] [Related]
4. Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice. Zhao HM; Huang XY; Zuo ZQ; Pan QH; Ao MY; Zhou F; Liu HN; Liu ZY; Liu DY World J Gastroenterol; 2013 Feb; 19(5):742-9. PubMed ID: 23430765 [TBL] [Abstract][Full Text] [Related]
8. A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis. Peran L; Camuesco D; Comalada M; Bailon E; Henriksson A; Xaus J; Zarzuelo A; Galvez J J Appl Microbiol; 2007 Oct; 103(4):836-44. PubMed ID: 17897185 [TBL] [Abstract][Full Text] [Related]
9. Bifidobacterium longum and VSL#3 Chen X; Fu Y; Wang L; Qian W; Zheng F; Hou X Dev Comp Immunol; 2019 Mar; 92():77-86. PubMed ID: 30227219 [TBL] [Abstract][Full Text] [Related]
10. The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment. Ekmekciu I; von Klitzing E; Fiebiger U; Neumann C; Bacher P; Scheffold A; Bereswill S; Heimesaat MM Front Cell Infect Microbiol; 2017; 7():167. PubMed ID: 28529928 [TBL] [Abstract][Full Text] [Related]
11. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. Peran L; Camuesco D; Comalada M; Nieto A; Concha A; Diaz-Ropero MP; Olivares M; Xaus J; Zarzuelo A; Galvez J World J Gastroenterol; 2005 Sep; 11(33):5185-92. PubMed ID: 16127750 [TBL] [Abstract][Full Text] [Related]
12. Divergent Effectiveness of Multispecies Probiotic Preparations on Intestinal Microbiota Structure Depends on Metabolic Properties. Biagioli M; Capobianco D; Carino A; Marchianò S; Fiorucci C; Ricci P; Distrutti E; Fiorucci S Nutrients; 2019 Feb; 11(2):. PubMed ID: 30717413 [TBL] [Abstract][Full Text] [Related]
14. Lactobacillus acidophilus Improves Intestinal Inflammation in an Acute Colitis Mouse Model by Regulation of Th17 and Treg Cell Balance and Fibrosis Development. Park JS; Choi JW; Jhun J; Kwon JY; Lee BI; Yang CW; Park SH; Cho ML J Med Food; 2018 Mar; 21(3):215-224. PubMed ID: 29336663 [TBL] [Abstract][Full Text] [Related]
15. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model. del Carmen S; Martín Rosique R; Saraiva T; Zurita-Turk M; Miyoshi A; Azevedo V; de Moreno de LeBlanc A; Langella P; Bermúdez-Humarán LG; LeBlanc JG J Clin Gastroenterol; 2014; 48 Suppl 1():S12-7. PubMed ID: 25291117 [TBL] [Abstract][Full Text] [Related]
16. Live and heat-killed probiotic Lactobacillus casei Lbs2 protects from experimental colitis through Toll-like receptor 2-dependent induction of T-regulatory response. Thakur BK; Saha P; Banik G; Saha DR; Grover S; Batish VK; Das S Int Immunopharmacol; 2016 Jul; 36():39-50. PubMed ID: 27107798 [TBL] [Abstract][Full Text] [Related]
17. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches. Alard J; Peucelle V; Boutillier D; Breton J; Kuylle S; Pot B; Holowacz S; Grangette C Benef Microbes; 2018 Feb; 9(2):317-331. PubMed ID: 29488412 [TBL] [Abstract][Full Text] [Related]
18. Dominant Negative FADD/MORT1 Inhibits the Development of Intestinal Intraepithelial Lymphocytes With a Marked Defect on CD8αα+TCRγδ+ T Cells. Zhang X; Huo L; Song L; Hu Z; Wang X; Han Y; Wang Y; Xu P; Zhang J; Hua ZC Front Immunol; 2018; 9():2038. PubMed ID: 30250469 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis. Fiorucci S; Distrutti E; Mencarelli A; Barbanti M; Palazzini E; Morelli A Digestion; 2002; 66(4):246-56. PubMed ID: 12592101 [TBL] [Abstract][Full Text] [Related]
20. Yogurt starter cultures of Streptococcus thermophilus and Lactobacillus bulgaricus ameliorate symptoms and modulate the immune response in a mouse model of dextran sulfate sodium-induced colitis. Wasilewska E; Zlotkowska D; Wroblewska B J Dairy Sci; 2019 Jan; 102(1):37-53. PubMed ID: 30343915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]